Strictly Pharmaceuticals ApS: Financial statements 2022

CVR: 42088838

Strictly Pharmaceuticals ApS (CVR 42088838) has filed annual accounts for 2022. In 2022, the company reported a net result of DKK -681. Equity amounted to DKK 5,976. The solvency ratio was 100%.

Profit/Loss: -681 kr.
Equity: 5,976 kr.
Total Assets: 5,976 kr.

Official annual report

View the official annual report directly on the page with a Pro subscription.

Keep an eye on Strictly Pharmaceuticals ApS

Get notified instantly about new financial statements, ownership changes, management changes and status changes.

Set up monitoring

Events in 2022

Søren Wonsild Glud joins Strictly Pharmaceuticals ApS as liquidatorMar 1, 2022

As of March 1, 2022, Søren Wonsild Glud is registered as liquidator of Strictly Pharmaceuticals ApS.

Søren Wonsild Glud steps down as director of Strictly Pharmaceuticals ApSMar 1, 2022

As of March 1, 2022, Søren Wonsild Glud has stepped down as director of Strictly Pharmaceuticals ApS.

Strictly Pharmaceuticals ApS enters liquidationMar 1, 2022

On March 1, 2022, Strictly Pharmaceuticals ApS entered liquidation.

Strictly Pharmaceuticals ApS publishes interim reportFeb 15, 2022

Strictly Pharmaceuticals ApS has published its interim report for the period January 31, 2021 – September 30, 2021.

About Strictly Pharmaceuticals ApS

Strictly Pharmaceuticals ApS was a Danish company of the type Anpartsselskab based in Farum, founded in 2021 and dissolved in 2023. The company was registered under the industry Investeringsselskaber. In 2022, the company reported a net result of DKK -681. Equity amounted to DKK 5,976.